MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Country |
 USA |
IPO year |
2013 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
3.34 M |
Market Cap[1] |
$ 36.6 M |
EBITDA (LTM) |
$ -5.28 M |
P/E (LTM) |
- |
P/S (LTM) |
2.66 |
EPS (LTM) |
-2.52 |
Other stocks of industry "Drug manufacturers"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Avadel Pharmaceuticals plc
AVDL
|
- | - | $ 2.06 B | Nasdaq Global Select Market |  France |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 3.12 | 0.97 % | $ 43.9 M | Nasdaq Global Select Market | USA |
 |
Cronos Group
CRON
|
$ 2.57 | -0.39 % | $ 1.35 B | Nasdaq Global Market |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | Canada |
 |
Bausch Health Companies
BHC
|
$ 5.72 | 2.14 % | $ 2.09 B | NYSE | Canada |
 |
Harrow Health
HROW
|
$ 37.1 | 3.26 % | $ 1.36 B | Nasdaq Global Market | USA |
 |
Aurora Cannabis
ACB
|
$ 3.48 | 1.46 % | $ 86.3 M | NYSE | Canada |
 |
Canopy Growth Corporation
CGC
|
$ 1.08 | 2.86 % | $ 116 M | Nasdaq Global Select Market | Canada |
 |
OrganiGram Holdings
OGI
|
$ 1.42 | 1.43 % | $ 402 M | Nasdaq Global Select Market | Canada |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
Relmada Therapeutics
RLMD
|
$ 7.38 | 1.23 % | $ 291 M | Nasdaq Global Select Market,SPB | USA |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
Evolus
EOLS
|
$ 4.33 | 1.41 % | $ 279 M | Nasdaq Global Market | USA |
 |
Emergent BioSolutions
EBS
|
$ 8.24 | 3.52 % | $ 422 M | NYSE,SPB | USA |
 |
Sundial Growers
SNDL
|
$ 1.37 | -3.52 % | $ 3.37 M | Nasdaq Global Select Market | Canada |
 |
Tilray
TLRY
|
$ 6.72 | 2.28 % | $ 4.15 B | Nasdaq Global Select Market | Canada |
 |
Organogenesis Holdings
ORGO
|
$ 2.38 | - | $ 313 M | Nasdaq Capital Market | USA |
 |
Pacira BioSciences
PCRX
|
$ 24.06 | 1.13 % | $ 1.11 B | Nasdaq Global Select Market,SPB | USA |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
Veru
VERU
|
$ 2.38 | - | $ 321 M | Nasdaq Capital Market | USA |
 |
Viatris
VTRS
|
$ 13.83 | 2.67 % | $ 16.6 B | Nasdaq Global Select Market,SPB | USA |
 |
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | USA |
 |
cbdMD
YCBD
|
$ 0.75 | 9.54 % | $ 3.23 M | NYSE American | USA |
 |
Assertio Holdings
ASRT
|
$ 18.02 | - | $ 115 M | Nasdaq Capital Market | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
SCYNEXIS
SCYX
|
$ 1.01 | 1.0 % | $ 50.4 M | Nasdaq Global Select Market | USA |
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | USA |
 |
Solid Biosciences
SLDB
|
$ 8.39 | 4.61 % | $ 734 M | Nasdaq Global Select Market,SPB | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 2.35 | 3.07 % | $ 2.92 M | Nasdaq Capital Market | USA |
 |
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | USA |
 |
Rockwell Medical
RMTI
|
$ 0.94 | 3.31 % | $ 33.8 M | Nasdaq Global Market | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
China Pharma Holdings
CPHI
|
$ 0.65 | 0.6 % | $ 2.79 M | NYSE American |  China |
 |
TherapeuticsMD
TXMD
|
$ 2.05 | -0.97 % | $ 23.7 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.